Press Releases

NEW YORK, Oct. 31, 2019 /PRNewswire/ -- With Alzheimer's Awareness Month beginning November 1st, the Alzheimer's Foundation of America (AFA) is encouraging people to remember four important things about Alzheimer's disease.

IRVINE, Calif., Oct. 31, 2019 /PRNewswire/ -- BIOLASE, Inc. (Nasdaq: BIOL), the global leader in dental lasers, today announced that it has secured a $3 million revolving line of credit from

FRANKLIN, Tenn., Oct. 31, 2019 /PRNewswire/ -- Community Healthcare Trust Incorporated (NYSE: CHCT) today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended September 30, 2019.  This dividend, in the amount of $0.4150 per share, is payable on

MECHANICSBURG, Pa., Oct. 31, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced results for its third quarter ended September 30, 2019.For the third quarter ended September 30, 2019, net operating revenues increased 9.9% to $1,393.3 million, compared to $1,267.4 million

OAKLAND, Calif., Oct. 31, 2019 /PRNewswire/ -- Kaiser Permanente, the nation's largest integrated health system, today announced a $650,000 contribution to provide immediate support for relief and recovery efforts in communities affected by the recent wildfires in Northern and Southern California.

STAINES-UPON-THAMES, United Kingdom, Oct. 31, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that UVADEX® (methoxsalen) has received regulatory approval in Australia by the Therapeutic Goods Administration (TGA) for extracor

WASHINGTON, Oct. 31, 2019 /PRNewswire/ -- The national conversation around the opioid epidemic was advanced today with the release of a new report, "Bringing Science to Bear on Opioids." Prepared by an expert panel formed by the Association of Schools and Programs of Public Health (ASPPH), the exhaustively researched report features dozens of recommendations

SOUTH PLAINFIELD, N.J., Oct. 31, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on October 25, 2019 it approved non-statutory stock options to purchase an aggregate of 339,875 shares of its common stock to 27 new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a compo

TORONTO, Oct. 31, 2019 /PRNewswire/ - Portage Biotech Inc. (CSE: PBT.U, OTC Markets: PTGEF) ("Portage" or the "Company") is providing the following  update on the status of efforts being made to revoke a failure to file cease trade order issued by the Ontario Securities Commission (the "OSC") on August 2, 2019 (the "FFCTO") against the

In a release issued under the same headline on October 29th by Curis, Inc., please note that in the first and second paragraphs of the release, financial results will be reported before Nasdaq market open, not after market close. The corrected release follows:Curis to Release Third Quarter Financial Results and Hold Conference Call on November 5, 2019